CAROTENUTO, ALFONSO
 Distribuzione geografica
Continente #
NA - Nord America 3.200
EU - Europa 2.004
AS - Asia 1.587
AF - Africa 58
SA - Sud America 19
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.876
Nazione #
US - Stati Uniti d'America 3.106
IT - Italia 753
SG - Singapore 697
CN - Cina 474
HK - Hong Kong 313
IE - Irlanda 222
RU - Federazione Russa 209
NL - Olanda 182
FI - Finlandia 180
UA - Ucraina 145
DE - Germania 119
CA - Canada 89
SE - Svezia 73
GB - Regno Unito 59
CI - Costa d'Avorio 54
IN - India 43
FR - Francia 21
VN - Vietnam 17
BR - Brasile 16
BE - Belgio 13
JP - Giappone 13
TR - Turchia 13
BG - Bulgaria 7
AT - Austria 5
IR - Iran 5
MX - Messico 4
BD - Bangladesh 3
ES - Italia 3
EU - Europa 3
KR - Corea 3
LT - Lituania 3
NZ - Nuova Zelanda 3
OM - Oman 3
AU - Australia 2
CH - Svizzera 2
MG - Madagascar 2
RO - Romania 2
AR - Argentina 1
AZ - Azerbaigian 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
GR - Grecia 1
KE - Kenya 1
LV - Lettonia 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 6.876
Città #
Chandler 585
Singapore 483
Hong Kong 313
Santa Clara 267
Naples 188
Amsterdam 174
Millbury 174
Princeton 169
Jacksonville 156
Ashburn 154
Nanjing 132
Boston 122
Napoli 115
Beijing 86
Ottawa 69
Wilmington 66
Des Moines 62
Woodbridge 55
Ann Arbor 46
Seattle 39
Nanchang 38
Shenyang 30
Hebei 24
Rome 22
Falls Church 21
Helsinki 20
Houston 19
Jiaxing 18
Tianjin 18
Boardman 16
Kronberg 16
Augusta 15
Milan 15
Norwalk 15
Toronto 15
Bologna 14
Dong Ket 14
Lawrence 14
Changsha 13
Columbus 12
Florence 12
Hangzhou 12
Washington 12
Dearborn 10
Los Angeles 9
Arce 8
Frankfurt am Main 8
Munich 8
Nakano 8
Pune 8
Orange 7
Guangzhou 6
Indiana 6
Kunming 6
London 6
Moscow 6
Nuremberg 6
Portici 6
Quarto 6
Salerno 6
Brussels 5
Dallas 5
Fairfield 5
Ningbo 5
Redwood City 5
Shanghai 5
Amorosi 4
Bengaluru 4
Catania 4
Dublin 4
Ixelles-Elsene 4
Mexico City 4
Newark 4
Paris 4
Sant'Antimo 4
Santa Maria Capua Vetere 4
Sarno 4
Sofia 4
Viterbo 4
Arzano 3
Etterbeek 3
Falkenstein 3
Hanoi 3
Ischia 3
Jinhua 3
Leawood 3
Mountain View 3
Mugnano di Napoli 3
New York 3
Pinole 3
Piombino 3
Potenza 3
San Giuliano Terme 3
San Mateo 3
Serino 3
Tappahannock 3
Turin 3
Albenga 2
Antananarivo 2
Ardabil 2
Totale 4.122
Nome #
Antimicrobial peptide Temporin-L complexed with anionic cyclodextrins results in a potent and safe agent against sessile bacteria 94
" Molecular Modelingof the Urotensin-II receptor Complex" 92
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides 84
Screening Platform toward New Anti-HIV Aptamers Set on Molecular Docking and Fluorescence Quenching Techniques 79
1H and 15N sequential assignment and secondary structure of the monomeric N67D mutant of bovine seminal ribonuclease 76
Unraveling the active conformation of urotensin II 74
Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration 72
Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta 70
Development of Antiviral Fusion Inhibitors: Short Modified Peptides Derived from the Transmembrane Glycoprotein of Feline Immunodeficiency Virus 64
Molecular Modeling of the Urotensin-UT Receptor Complex 62
A nutraceutical formulation based on Annurca apple polyphenolic extract is effective on intestinal cholesterol absorption: A randomised, placebo-controlled, crossover study 62
Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities 61
In vitro evaluation of tumor targeting ability of a parenteral enoxaparin-coated self-emulsifying drug delivery system 61
"3D Structural analysis of Urotensin-II analogues in membrane mimetic environment" 60
Unraveling the active conformation of urotensin II 60
A novel route to synthesize Freidinger lactams by microwave irradiation 58
Discovery of New Potent Ligands at Human Urotensin-II Receptor 58
An investigation into the origin of the biased agonism associated with the urotensin II receptor activation 58
Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists 58
A New, Potent Urotensin II Receptor Peptide Agonist Containing a Pen Residue at the Disulfide Bridge 57
Morphicetin analogues containing a new β-turn thiazolidine mimetic 57
Disulfide bond replacement with 1,4‐ and 1,5‐disubstituted [1,2,3]‐triazole on C‐X‐C chemokine receptor type 4 (CXCR4) peptide ligands: small changes that make big differences 55
Synthesis of a Dicarba-Analog of Octreotide Keeping the Type II Beta-Turn of the Pharmacophore in Water Solution 54
D-Amino Acids Containing Temporin L Analogues 53
Nondenaturing polyacrylamide gel electrophoresis to study the dissociation of the p53·MDM2/X complex by potentially anticancer compounds 53
Development and Identification of a Novel Anti-HIV-1 Peptide Derived by Modification of the N-Terminal Domain of HIV-1 Integrase 53
Native PAGE to study the interaction between the oncosuppressor p53 and its protein ligands 51
Retro-Inverso Analogue of the Antiviral Octapeptide C8 Inhibits Feline Immunodeficiency Virus in Serum 51
Urotensin-II Receptor Antagonists 51
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells 51
Design and synthesis of the small libraries of peptidomimetics based on thiazolidine moiety 50
An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule 50
Structure-Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist 50
Solution structure of monomeric bovine seminal ribonuclease 49
SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors 49
12-Keto-Porrigenin and the Unique 2,3-Seco-Porrigenin, New Antiproliferative Sapogenins isolated from Allium porrum. 49
Design, Synthesis, and Evaluation of Gluten Peptide Analogs as Selective 401 Inhibitors of Human TG2 49
The flavonoids of Allium Neapolitanum. 48
Recognition Properties of V3-Specific Antibodies to V3 Loop Peptides Derived from HIV-1 Gp120 Presented in Multiple Conformations 48
Design and Synthesis of Spirotryprostatin-inspired Diketopiperazine Systemsfrom Prolyl Spirooxoindolethiazolidine Derivatives 48
Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position9 48
Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor 48
Breast tumor cell invasion and pro-invasive activity of cancer-associated fibroblasts co-targeted by novel urokinase-derived decapeptides 48
Urotensin-II Receptor Ligands. From Agonist to Antagonist Activity 47
Structure-function Relationships and Conformational Properties of alpha-MSH(6-13) Analogues with Candidacidal Activity 47
A proteomic approach to characterize a native antigen involved in autoantibody response in multiple sclerosis by a structure-based designed glycopeptide 47
Conformation-Activity Relationship of Designed Glycopeptides as Synthetic Probes for the Detection of Autoantibodies, Biomarkers of Multiple Sclerosis 46
Novel α-MSH peptide analogues with broad spectrum antimicrobial activity. 46
Design, synthesis, and conformational analysis of Melanotropin analogues of MTII and SHU9119. 46
Design, Synthesis, and Conformational Analysis of Melanotropin Analogues of MTII and SHU9119 46
HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein-Protein Interactions by NMR 46
Urotensin-II Receptor Peptide Agonists 45
"Urotensin-II (U-II) analogues containing modifications at disulfide bridge Synthesis, biological and conformational studies" 45
The Outcomes of Decorated Prolines in the Discovery of Antimicrobial Peptides from Temporin-L 45
First-in-Class Cyclic Temporin L Analogue: Design, Synthesis, and Antimicrobial Assessment 45
Identification of the Spiro(oxindole-3,3’-thiazolidine)-Based Derivatives as Potential p53 Activity Modulators 44
Design, Synthesis, and Cytotoxic Evaluation of AcylDerivatives of 3-Aminonaphtho[2,3-b]thiophene-4,9-dione, a Quinone-Based System 44
A De Novo Designed Library of Linear Helical Peptides: An Exploratory Tool in the Discovery of Protein-Protein Interaction Modulators 44
ANALOGHI DELLA TEMPORINA L CON ATTIVITÀ ANTI-INFIAMMATORIA E ANTIMICROBICA 44
A novel β-hairpin peptide derived from the ARC repressor selectively interacts with the major groove of B-DNA 44
THE FLAVONOIDS OF ALLIUM URSINUM 43
Structural Studies on Hgr3 Orphan Receptor Ligand Prolactin-Releasing Peptide. 43
An N-Glucosylated Peptide Detecting Disease-Specific Autoantibodies, Biomarkers of Multiple Sclerosis 43
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors 43
New Anticancer Agents Mimicking Protein Recognition Motifs. 43
Host Defense Peptide-derived Privileged Scaffolds for Anti-infective Drug Discovery 43
Discovery of 2,3-Diaminoindole Derivatives as a Novel Class of NOD Antagonists 42
3D structure of monomeric bovine seminal ribonuclease by heteronuclear NMR 42
NMR analysis of synthetic peptides agonist to PTPRJ, a receptor-type protein tyrosine phosphatase with tumor suppressor activity. 41
Urantide Conformation and Interaction with the Urotensin-II Receptor 41
Role of Lipoylation of the Immunodominant Epitope of Pyruvate Dehydrogenase Complex: Toward a Peptide-Based Diagnostic Assay for Primary Biliary Cirrhosis 41
New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide 40
New insight into the binding mode of cyclic melanocortin ligands at the MC4 receptor 40
Porrigenins A and B, novel cytotoxic and antiproliferative sapogenins isolated from Allium porrum 40
B-Hairpin Glycopeptides as Mimetic Autoantigens in Multiple Sclerosis 40
Antiproliferative sesterterpenes from the Caribbean sponge Cacospongia cf. linteiformis. 40
Amino acid derivatives as new zinc binding groups for the design of selective matrix metalloproteinase inhibitors 40
NEW INSIGHT INTO THE BINDING MODE OF CYCLIC MELANOCORTIN LIGANDS AT THE MC4 RECEPTOR 40
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 40
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma 39
Development of Cyclic Peptide Inhibitors of GRK2 39
Stereostructures of new bioactive sesterterpenes isolated from the Caribbean sponge Cacospongia cf. linteiformis 39
Theoretical and experimental studies on the interaction of biphenyl ligands with human and murine PD-L1: Up-to-date clues for drug design 38
SOLUTION STRUCTURE OF MONOMERIC BOVINE SEMINAL RIBONUCLEASE 38
Spiro[(dihydropyrazin-2,5-dione)-6,3’-(2’,3’-dihydrothieno[2,3-b]naphtho-4’,9’-dione)]-Based Cytotoxic Agents: Structure-Activity Relationship Studies on the Substituent at N4-Position of the Diketopiperazine Domain 38
Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta. 38
Combinatorial Approach in the Synthesis of a Small Library of β-Turn Structures Based on Thiazolidine Moiety 38
New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide. 38
Lead Optimization of P5U and Urantide: Discovery of Novel Potent Ligands at the Urotensin-II Receptor 38
Investigation on side-product formation during the synthesis of a lactoferrin-derived lactam-bridged cyclic peptide 38
Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2’,3’-cyclic nucleotide-3’-phosphodiesterase 37
UT RECEPTOR LIGANDS. SWITCHING FROM AGONIST TO ANTAGONIST ACTIVITY 37
beta-HAIRPIN GLYCOPEPTIDES AS MIMETIC AUTOANTIGENS IN MULTIPLE SCLEROSIS 37
Novel cyclic biphalin analogue with improved antinociceptive properties. 37
SAR Study and Conformational Analysis of a Series of Novel GRK2 Peptide inhibitors 37
Structure-Activity Relationship Studies, SPR Affinity Characterization, and Conformational Analysis of Peptides That Mimic the HNK-1 Carbohydrate Epitope 37
Design, Synthesis, Conformational Analysis, and Biological Studies of Urotensin II Lactam analogues 36
The EH1 Domain of Eps15 Is Structurally Classified as a Member of the S100 Subclass of EF-Hand-Containing Proteins 36
Synthesis and pharmacological evaluation of some 4-oxo-quinoline-2-carboxylic acid derivatives as anti-inflammatory and analgesic agents 36
Structure and absolute stereochemistry of the new cyclolinteinol and cyclolinteinol acetate, macrophage activation modulators 36
Totale 4.866
Categoria #
all - tutte 33.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.340


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020226 0 0 0 0 0 0 0 12 6 60 78 70
2020/2021572 35 37 48 35 61 138 36 14 47 22 75 24
2021/20221.035 25 7 12 26 19 22 16 27 234 81 121 445
2022/20231.361 198 102 54 127 153 149 9 121 192 169 62 25
2023/2024989 55 139 171 56 64 93 15 127 13 16 174 66
2024/20251.819 254 307 56 73 85 318 512 214 0 0 0 0
Totale 7.217